(Q43201418)

16 November 2017

Aromatase inhibitors alone or in sequence with tamoxifen - clinical evaluation of the BIG 1-98 trial (English)

1 reference

16 November 2017

1 reference

2

Aman U Buzdar

1 reference

16 November 2017

Catherine M Kelly

1

1 reference

PubMed ID

20053139

16 November 2017

language of work or name

English

0 references

publication date

1 February 2010

1 reference

Expert Opinion on Pharmacotherapy

16 November 2017

1 reference

16 November 2017

11

1 reference

16 November 2017

3

1 reference

16 November 2017

489-492

1 reference

Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer

16 November 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656560903501551

Advances in adjuvant endocrine therapy for postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903501551

Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903501551

A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903501551

Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903501551

Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903501551

10.1517/14656560903501551

21 January 2018

Identifiers

DOI

1 reference

16 November 2017

1 reference

PubMed ID

20053139